In addition to evaluation of SA-β-Gal expression in tumor-treated CD4+ T cells, we investigated the effects of TLR8 signaling on the expression of other senescence-associated markers and function of tumor-induced senescent T cells. This evidence concerns the gene CD4 and neoplasm.